Would you ever consider managing HR+ DCIS non-surgically?

Topics: Breast Cancer • Medical Oncology • Ductal Carcinoma In Situ • Breast Cancer, Non-metastatic

If so, in what situations?

Answer from: Medical Oncologist at Academic Institution

In the wake of the COVID-19 pandemic, I think we've all gained experience managing early stage (0-1) HR+ breast cancers with endocrine therapy as a stop-gap until surgery was possible. However, outside of a clinical trial or unusual circumstances, I would not normally consider managing HR+ DCIS non-...

Comments

Medical Oncologist at Aspirus UW Cancer Center
I agree

Medical Oncologist at MedStar Washington Hospital Center, MedStar Georgetown University Hospital
Dr. @Tevaarwerk, Would you consider managin...

Related Questions